Published in J Clin Invest on January 15, 1996
Cell surface receptors for signal transduction and ligand transport: a design principles study. PLoS Comput Biol (2007) 1.21
Sterol-independent repression of low density lipoprotein receptor promoter by peroxisome proliferator activated receptor gamma coactivator-1alpha (PGC-1alpha). Exp Mol Med (2009) 0.89
Growth hormone and bile acid synthesis. Key role for the activity of hepatic microsomal cholesterol 7alpha-hydroxylase in the rat. J Clin Invest (1997) 0.89
Lipoprotein receptors in acute myelogenous leukemia: failure to detect increased low-density lipoprotein (LDL) receptor numbers in cell membranes despite increased cellular LDL degradation. Am J Pathol (1998) 0.81
Hormonal regulation of the human sterol 27-hydroxylase gene CYP27A1. Biochem J (2003) 0.80
The roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolism. Biomed Res Int (2013) 0.79
Fasting levels of growth hormone are associated with carotid intima media thickness but are not affected by fluvastatin treatment. BMC Cardiovasc Disord (2017) 0.75
A receptor-mediated pathway for cholesterol homeostasis. Science (1986) 19.28
Regulation of the mevalonate pathway. Nature (1990) 18.25
Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science (1988) 13.54
Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med (1987) 13.50
Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med (1990) 6.43
Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH) N Engl J Med (1990) 4.55
Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J Lipid Res (1993) 3.64
Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog. Proc Natl Acad Sci U S A (1981) 2.82
Increased binding of low density lipoprotein to liver membranes from rats treated with 17 alpha-ethinyl estradiol. J Biol Chem (1979) 2.72
Lipoproteins, cardiovascular disease, and death. The Framingham study. Arch Intern Med (1981) 2.42
Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol. N Engl J Med (1990) 2.06
Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. J Clin Endocrinol Metab (1980) 1.96
Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver. J Clin Invest (1988) 1.40
Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc Natl Acad Sci U S A (1992) 1.34
Metabolic heterogeneity of apolipoprotein B in the rat. J Lipid Res (1981) 1.27
Hepatic mRNA levels for the LDL receptor and HMG-CoA reductase show coordinate regulation in vivo. J Lipid Res (1992) 1.14
Low density lipoprotein receptor-binding activity in human tissues: quantitative importance of hepatic receptors and evidence for regulation of their expression in vivo. Proc Natl Acad Sci U S A (1990) 1.13
Influence of age on the metabolism of plasma low density lipoproteins in healthy males. J Clin Invest (1991) 1.07
Apolipoprotein B messenger RNA editing in the rat liver. Modulation by fasting and refeeding a high carbohydrate diet. J Biol Chem (1990) 1.07
Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus. J Clin Invest (1992) 1.04
Effects of hypothyroidism and high-fat feeding on mRNA concentrations for the low-density-lipoprotein receptor and on acyl-CoA:cholesterol acyltransferase activities in rat liver. Biochem J (1991) 1.02
Stimulation of rat hepatic low density lipoprotein receptors by glucagon. Evidence of a novel regulatory mechanism in vivo. J Clin Invest (1993) 1.00
Hepatic metabolism of cholesterol in Crohn's disease. Effect of partial resection of ileum. Gastroenterology (1991) 0.95
REPR and complementation factor(s) interact to modulate rat apolipoprotein B mRNA editing in response to alterations in cellular cholesterol flux. J Lipid Res (1994) 0.93
Regulation of low-density-lipoprotein-receptor mRNA by insulin in human hepatoma Hep G2 cells. Eur J Biochem (1989) 0.92
Hepatic cholesterol metabolism in estrogen-treated men. Gastroenterology (1992) 0.92
Growth hormone and insulin-like growth factor-I increase macrophage uptake and degradation of low density lipoprotein. Endocrinology (1992) 0.91
Hormonal regulation of serum lipoprotein(a) levels. Contrasting effects of growth hormone and insulin-like growth factor-I. Arterioscler Thromb Vasc Biol (1995) 0.91
Primary structure of rat insulin-like growth factor-I and its biological activities. J Biol Chem (1989) 0.87
Loss of resistance to dietary cholesterol in the rat after hypophysectomy: importance of the presence of growth hormone for hepatic low density lipoprotein-receptor expression. Proc Natl Acad Sci U S A (1993) 0.84
Stimulation of in vitro triglyceride synthesis in the rat hepatocyte by growth hormone treatment in vivo. Endocrinology (1988) 0.83
Continuous but not intermittent administration of growth hormone to hypophysectomized rats increases apolipoprotein-E secretion from cultured hepatocytes. Endocrinology (1994) 0.83
1994 Mack-Forster Award Lecture. Review. Studies on the regulation of hepatic cholesterol metabolism in humans. Eur J Clin Invest (1995) 0.83
Effects of growth hormone on apolipoprotein-B (apoB) messenger ribonucleic acid editing, and apoB 48 and apoB 100 synthesis and secretion in the rat liver. Endocrinology (1992) 0.83
Growth hormone and hepatic lipoprotein metabolism. Curr Opin Lipidol (1994) 0.82
In vivo growth hormone treatment stimulates secretion of very low density lipoprotein by the isolated perfused rat liver. Endocrinology (1992) 0.82
Hormonal and nutritional stimuli modulate apolipoprotein B mRNA editing in mouse liver. Biochem Biophys Res Commun (1992) 0.80
Hormonal regulation of the hepatic low density lipoprotein receptor and the catabolism of low density lipoproteins: relationship with the secretion of very low density lipoproteins. Prog Lipid Res (1991) 0.80
The insulin-like growth factor, somatomedin-C, modulates low density lipoprotein metabolism by swine granulosa cells. Endocrinology (1987) 0.79
Growth hormone specifically stimulates the expression of low density lipoprotein receptors in human hepatoma cells. Endocrinology (1995) 0.79
Insulin-like growth factor-I and growth hormone have different effects on serum lipoproteins and secretion of lipoproteins from cultured rat hepatocytes. Endocrinology (1994) 0.78
Role of the liver for the receptor-mediated catabolism of low-density lipoprotein in the 17 alpha-ethinylestradiol-treated rat. Biochim Biophys Acta (1987) 0.78
Growth hormone but not gonadal steroids influence lipoprotein lipase and hepatic lipase activity in hypophysectomized rats. J Endocrinol (1994) 0.77
Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J Intern Med (2006) 2.70
HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med (1998) 2.68
Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia. Lancet (1990) 2.55
Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans. Circulation (1999) 2.27
Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol. N Engl J Med (1990) 2.06
Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice. J Clin Invest (2001) 1.95
Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochem Biophys Res Commun (2000) 1.94
Ceftriaxone: renal and biliary excretion and effect on the colon microflora. J Antimicrob Chemother (1982) 1.65
Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene. J Biol Chem (1998) 1.65
Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum. J Clin Invest (1982) 1.61
Growth hormone and insulin-like growth factor-1 in acute myocardial infarction. Eur Heart J (2000) 1.55
Immunodiffusion studies on Escherichia coli. 1. Identification of O, K and H antigens in an O6 strain. Acta Pathol Microbiol Scand (1969) 1.54
Bile acid kinetics and biliary lipid composition in cystic fibrosis. J Hepatol (1996) 1.51
Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver. J Lipid Res (1987) 1.50
Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia. Am J Med (1993) 1.50
Risk for fatal statin-induced rhabdomyolysis as a consequence of misinterpretation of 'evidence-based medicine'. J Intern Med (2005) 1.48
Biliary lipid composition during treatment with different hypolipidaemic drugs. Eur J Clin Invest (1979) 1.48
Secretion and composition of bile after human liver transplantation: studies on the effects of cyclosporine and tacrolimus. Transplantation (1997) 1.43
LXRβ activation increases intestinal cholesterol absorption, leading to an atherogenic lipoprotein profile. J Intern Med (2012) 1.43
Cloning and expression of cDNA of human delta 4-3-oxosteroid 5 beta-reductase and substrate specificity of the expressed enzyme. Eur J Biochem (1994) 1.40
Evidence for the absorption of bile acids in the proximal small intestine of normo- and hyperlipidaemic subjects. Gut (1976) 1.39
Enrichment of HFE mutations in Swedish patients with familial and sporadic form of porphyria cutanea tarda. J Intern Med (2004) 1.39
Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia. J Lipid Res (1978) 1.35
Type III hyperlipoproteinemia: recent insights into the genetic defect of familial dysbetalipoproteinemia. Adv Intern Med (1984) 1.34
Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc Natl Acad Sci U S A (1992) 1.34
Functional and morphological characterization of cultures of Kupffer cells and liver endothelial cells prepared by means of density separation in Percoll, and selective substrate adherence. Cell Tissue Res (1985) 1.31
Influence of age on secretion of cholesterol and synthesis of bile acids by the liver. N Engl J Med (1985) 1.28
Autosomal recessive hypercholesterolaemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment. J Intern Med (2004) 1.26
Lipoprotein profiles in plasma and interstitial fluid analyzed with an automated gel-filtration system. Eur J Clin Invest (2006) 1.26
Thyroid hormone receptor beta-deficient mice show complete loss of the normal cholesterol 7alpha-hydroxylase (CYP7A) response to thyroid hormone but display enhanced resistance to dietary cholesterol. Mol Endocrinol (2000) 1.22
Regulation of hepatic lipoprotein receptors in the dog. Rapid regulation of apolipoprotein B,E receptors, but not of apolipoprotein E receptors, by intestinal lipoproteins and bile acids. J Clin Invest (1983) 1.22
Individual bile acids in portal venous and systemic blood serum of fasting man. Gastroenterology (1977) 1.20
Acoustic tumors. J Neurosurg (1967) 1.19
Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance. Clin Endocrinol (Oxf) (2001) 1.18
Progressive bilateral thinning of the parietal bones. Skeletal Radiol (1982) 1.18
Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19. J Intern Med (2011) 1.17
Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia. J Clin Invest (1995) 1.16
Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy. Proc Natl Acad Sci U S A (1990) 1.15
Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma. J Clin Invest (1992) 1.13
Low density lipoprotein receptor-binding activity in human tissues: quantitative importance of hepatic receptors and evidence for regulation of their expression in vivo. Proc Natl Acad Sci U S A (1990) 1.13
Interindividual variability in biliary excretion of ceftriaxone: effects on biliary lipid metabolism and on intestinal microflora. Eur J Clin Invest (1988) 1.11
The peroxisome proliferator-activated receptor alpha (PPARalpha) regulates bile acid biosynthesis. J Biol Chem (2000) 1.10
Postprandial serum bile acids in healthy man. Evidence for differences in absorptive pattern between individual bile acids. Gut (1977) 1.08
Influence of age on the metabolism of plasma low density lipoproteins in healthy males. J Clin Invest (1991) 1.07
Lack of association between apolipoprotein E allele epsilon 4 and sporadic Alzheimer's disease. Neurosci Lett (1994) 1.06
Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levels. J Intern Med (1990) 1.05
Acetabular component migration in total hip arthroplasty using CT and a semiautomated program for volume merging. Acta Radiol (2002) 1.05
Biliary lipid composition in normo- and hyperlipoproteinemia. Gastroenterology (1980) 1.04
Influence of deoxycholic acid on biliary lipids in man. Clin Sci Mol Med (1977) 1.03
Structural characterization of the gene encoding rat 25-hydroxyvitamin D3 24-hydroxylase. Biochemistry (1993) 1.02
Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism. J Intern Med (2013) 1.02
Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis. Gastroenterology (1983) 1.02
Fluorescent dopa reaction of nevi and melanomas. Arch Dermatol (1966) 1.01
Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface. J Lipid Res (2000) 1.00
Hypocalcaemia with zonular cataract due to idiopathic hypoparathyroidism. With a note on the prevalence of severe hypocalcaemia in a health screening. Acta Med Scand (1978) 1.00
Stimulation of rat hepatic low density lipoprotein receptors by glucagon. Evidence of a novel regulatory mechanism in vivo. J Clin Invest (1993) 1.00
Expression of sterol 12alpha-hydroxylase alters bile acid pool composition in primary rat hepatocytes and in vivo. Gastroenterology (2001) 0.99
Individual serum bile acid concentrations in normo- and hyperlipoproteinemia as determined by mass fragmentography: relation to bile acid pool size. J Lipid Res (1978) 0.99
Hepatic cholesterol metabolism in human obesity. Hepatology (1997) 0.99
Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: relation to cholesterol gallstone disease and effects of cholic acid and chenodeoxycholic acid treatment. J Lipid Res (1981) 0.99
Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients. J Lipid Res (1990) 0.98
Low density lipoprotein receptor activity in human intracranial tumors and its relation to the cholesterol requirement. Cancer Res (1990) 0.98
On the possible use of the serum level of 7 alpha-hydroxycholesterol as a marker for increased activity of the cholesterol 7 alpha-hydroxylase in humans. J Lipid Res (1987) 0.97
Structure and chromosomal assignment of the sterol 12alpha-hydroxylase gene (CYP8B1) in human and mouse: eukaryotic cytochrome P-450 gene devoid of introns. Genomics (1999) 0.97
Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem (1993) 0.97
Regulation of sterol 12alpha-hydroxylase and cholic acid biosynthesis in the rat. Gastroenterology (2000) 0.97
Human evidence that the apolipoprotein a-II gene is implicated in visceral fat accumulation and metabolism of triglyceride-rich lipoproteins. Circulation (2001) 0.96
Hepatic metabolism of cholesterol in Crohn's disease. Effect of partial resection of ileum. Gastroenterology (1991) 0.95
Bile acids and lipoprotein metabolism: effects of cholestyramine and chenodeoxycholic acid on human hepatic mRNA expression. Biochem Biophys Res Commun (2007) 0.95
Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction. Am J Med (2001) 0.95
Estrogen-induced gallstone formation in males. Relation to changes in serum and biliary lipids during hormonal treatment of prostatic carcinoma. J Clin Invest (1989) 0.94
Bile acid synthesis in humans: regulation of hepatic microsomal cholesterol 7 alpha-hydroxylase activity. Gastroenterology (1989) 0.94
Complications of cerebral angiography. Neuroradiology (1977) 0.94
Effects of estrogen on low density lipoprotein metabolism in males. Short-term and long-term studies during hormonal treatment of prostatic carcinoma. J Clin Invest (1989) 0.94
Effects of somatostatin on hepatic bile formation. Gastroenterology (1989) 0.94
Bile acid kinetics in relation to endogenous tryglyceride metabolism in various types of hyperlipoproteinemia. J Lipid Res (1978) 0.93
Bile acid synthesis in man: assay of hepatic microsomal cholesterol 7 alpha-hydroxylase activity by isotope dilution-mass spectrometry. J Lipid Res (1986) 0.93
Lipoprotein metabolism in the fat Zucker rat: reduced basal expression but normal regulation of hepatic low density lipoprotein receptors. Endocrinology (1997) 0.93
Model studies on acetabular component migration in total hip arthroplasty using CT and a semiautomated program for volume merging. Acta Radiol (2003) 0.92
Biliary lipid output and bile acid kinetics in cholesterol gallstone disease. Evidence for an increased hepatic secretion of cholesterol in Swedish patients. Gastroenterology (1985) 0.92
Bile acid metabolism in hereditary forms of hypertriglyceridemia: evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia. Proc Natl Acad Sci U S A (1987) 0.92
Genes involved in initial steps of bile acid synthesis. Curr Opin Lipidol (2001) 0.92
Hepatic cholesterol metabolism in estrogen-treated men. Gastroenterology (1992) 0.92
Bile acid sequestrants: mechanisms of action on bile acid and cholesterol metabolism. Eur J Clin Pharmacol (1991) 0.91
Hormonal regulation of serum lipoprotein(a) levels. Contrasting effects of growth hormone and insulin-like growth factor-I. Arterioscler Thromb Vasc Biol (1995) 0.91
Molecular characterization of the complement activating protein in the venom of the Indian cobra (Naja N. siamensis). Mol Immunol (1981) 0.91
Prevalence of gallbladder disease in hyperlipoproteinemia. Dig Dis Sci (1979) 0.90
Studies on LXR- and FXR-mediated effects on cholesterol homeostasis in normal and cholic acid-depleted mice. J Lipid Res (2005) 0.90
Expression of very low density lipoprotein receptor in the vascular wall. Analysis of human tissues by in situ hybridization and immunohistochemistry. Am J Pathol (1996) 0.90
Analysis of the ileal bile acid transporter gene, SLC10A2, in subjects with familial hypertriglyceridemia. Arterioscler Thromb Vasc Biol (2001) 0.90
Unique patient with cerebrotendinous xanthomatosis. Evidence for presence of a defect in a gene that is not identical to sterol 27-hydroxylase. J Intern Med (2007) 0.89
Growth hormone and bile acid synthesis. Key role for the activity of hepatic microsomal cholesterol 7alpha-hydroxylase in the rat. J Clin Invest (1997) 0.89
Oestrogen-induced changes in lipoprotein metabolism: role in prevention of atherosclerosis in the cholesterol-fed rabbit. Eur J Clin Invest (1989) 0.89
Thyroid hormone suppresses hepatic sterol 12alpha-hydroxylase (CYP8B1) activity and messenger ribonucleic acid in rat liver: failure to define known thyroid hormone response elements in the gene. Biochim Biophys Acta (1999) 0.88
Early determination of serum lipids and apolipoproteins in acute myocardial infarction: possibility for immediate intervention. J Intern Med (1989) 0.88
Novel homozygous and compound heterozygous mutations of sterol 27-hydroxylase gene (CYP27) cause cerebrotendinous xanthomatosis in three Japanese patients from two unrelated families. J Lipid Res (1997) 0.88